Manufacturing roundup: Touchlight nets $2M grant from the Gates Foundation; Experic closes $14M Series B
The manufacturer of the “Doggybone DNA” synthetic vector has netted deals with big names, the latest of which is a grant from the Bill & Melinda Gates Foundation to help further Touchlight’s “preclinical development” of its vaccine platform.
The vaccine program aims to build on evidence that the synthetic DNA the company produces can produce strong antibodies and durable T cell responses following vaccine administration.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.